BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28122182)

  • 1. Symmetrically Substituted Xanthone Amphiphiles Combat Gram-Positive Bacterial Resistance with Enhanced Membrane Selectivity.
    Lin S; Koh JJ; Aung TT; Lim F; Li J; Zou H; Wang L; Lakshminarayanan R; Verma C; Wang Y; Tan DT; Cao D; Beuerman RW; Ren L; Liu S
    J Med Chem; 2017 Feb; 60(4):1362-1378. PubMed ID: 28122182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro and in Vivo Evaluation of Membrane-Active Flavone Amphiphiles: Semisynthetic Kaempferol-Derived Antimicrobials against Drug-Resistant Gram-Positive Bacteria.
    Lin S; Li H; Tao Y; Liu J; Yuan W; Chen Y; Liu Y; Liu S
    J Med Chem; 2020 Jun; 63(11):5797-5815. PubMed ID: 32400157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid modified xanthone derivatives: novel, highly promising membrane-active antimicrobials for multidrug-resistant Gram-positive bacterial infections.
    Koh JJ; Lin S; Aung TT; Lim F; Zou H; Bai Y; Li J; Lin H; Pang LM; Koh WL; Salleh SM; Lakshminarayanan R; Zhou L; Qiu S; Pervushin K; Verma C; Tan DT; Cao D; Liu S; Beuerman RW
    J Med Chem; 2015 Jan; 58(2):739-52. PubMed ID: 25474410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Membrane-Active Honokiol/Magnolol Amphiphiles as Potent Antibacterial Agents against Methicillin-Resistant
    Guo Y; Hou E; Wen T; Yan X; Han M; Bai LP; Fu X; Liu J; Qin S
    J Med Chem; 2021 Sep; 64(17):12903-12916. PubMed ID: 34432450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bottromycin derivatives: efficient chemical modifications of the ester moiety and evaluation of anti-MRSA and anti-VRE activities.
    Kobayashi Y; Ichioka M; Hirose T; Nagai K; Matsumoto A; Matsui H; Hanaki H; Masuma R; Takahashi Y; Omura S; Sunazuka T
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6116-20. PubMed ID: 20833545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel fragment based strategy for membrane active antimicrobials against MRSA.
    Li J; Liu S; Koh JJ; Zou H; Lakshminarayanan R; Bai Y; Pervushin K; Zhou L; Verma C; Beuerman RW
    Biochim Biophys Acta; 2015 Apr; 1848(4):1023-31. PubMed ID: 25582665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semisynthetic Flavone-Derived Antimicrobials with Therapeutic Potential against Methicillin-Resistant Staphylococcus aureus (MRSA).
    Lin S; Koh JJ; Aung TT; Sin WLW; Lim F; Wang L; Lakshminarayanan R; Zhou L; Tan DTH; Cao D; Beuerman RW; Ren L; Liu S
    J Med Chem; 2017 Jul; 60(14):6152-6165. PubMed ID: 28636355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold Nanoclusters for Targeting Methicillin-Resistant Staphylococcus aureus In Vivo.
    Xie Y; Liu Y; Yang J; Liu Y; Hu F; Zhu K; Jiang X
    Angew Chem Int Ed Engl; 2018 Apr; 57(15):3958-3962. PubMed ID: 29423995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid conjugated pyridinium cationic amphiphiles as antibacterial agents and self-assembling nano carriers.
    Walvekar P; Gannimani R; Rambharose S; Mocktar C; Govender T
    Chem Phys Lipids; 2018 Aug; 214():1-10. PubMed ID: 29730266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of amphiphilic xanthone-based, membrane-targeting antimicrobials with improved membrane selectivity.
    Zou H; Koh JJ; Li J; Qiu S; Aung TT; Lin H; Lakshminarayanan R; Dai X; Tang C; Lim FH; Zhou L; Tan AL; Verma C; Tan DT; Chan HS; Saraswathi P; Cao D; Liu S; Beuerman RW
    J Med Chem; 2013 Mar; 56(6):2359-73. PubMed ID: 23441632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel bis-cyclic guanidines as potent membrane-active antibacterial agents with therapeutic potential.
    Teng P; Nimmagadda A; Su M; Hong Y; Shen N; Li C; Tsai LY; Cao J; Li Q; Cai J
    Chem Commun (Camb); 2017 Oct; 53(87):11948-11951. PubMed ID: 29052670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrophobicity-Modulated Small Antibacterial Molecule Eradicates Biofilm with Potent Efficacy against Skin Infections.
    Konai MM; Barman S; Issa R; MacNeil S; Adhikary U; De K; Monk PN; Haldar J
    ACS Infect Dis; 2020 Apr; 6(4):703-714. PubMed ID: 32058691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Update of antimicrobial resistance in Gram-positive microorganisms].
    Cercenado E
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():10-5. PubMed ID: 21477699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005-2010).
    Zhao C; Sun H; Wang H; Liu Y; Hu B; Yu Y; Sun Z; Chu Y; Cao B; Liao K; Lei J; Hu Z; Zhang L; Zhang X; Xu Y; Wang Z; Chen M
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):174-81. PubMed ID: 22521693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telavancin: mechanisms of action, in vitro activity, and mechanisms of resistance.
    Karlowsky JA; Nichol K; Zhanel GG
    Clin Infect Dis; 2015 Sep; 61 Suppl 2():S58-68. PubMed ID: 26316559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftaroline fosamil: a new cephalosporin active against resistant Gram-positive organisms including MRSA.
    Garrison MW; Kawamura NM; Wen MM
    Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1087-103. PubMed ID: 23167512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neofiscalin A and fiscalin C are potential novel indole alkaloid alternatives for the treatment of multidrug-resistant Gram-positive bacterial infections.
    Bessa LJ; Buttachon S; Dethoup T; Martins R; Vasconcelos V; Kijjoa A; Martins da Costa P
    FEMS Microbiol Lett; 2016 Aug; 363(15):. PubMed ID: 27268269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tolerance and heteroresistance in Gram-positive microorganisms].
    Morosini MI; Cantón R
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():16-22. PubMed ID: 21477700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonpeptidic Amphiphilic Xanthone Derivatives: Structure-Activity Relationship and Membrane-Targeting Properties.
    Koh JJ; Zou H; Lin S; Lin H; Soh RT; Lim FH; Koh WL; Li J; Lakshminarayanan R; Verma C; Tan DT; Cao D; Beuerman RW; Liu S
    J Med Chem; 2016 Jan; 59(1):171-93. PubMed ID: 26681070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Biosurfactant-Inspired Heptapeptide with Improved Specificity to Kill MRSA.
    Liu Y; Ding S; Dietrich R; Märtlbauer E; Zhu K
    Angew Chem Int Ed Engl; 2017 Feb; 56(6):1486-1490. PubMed ID: 28106348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.